** Shares of Kleenex tissue maker Kimberly-Clark KMB.N down 1.1% at $129.95 premarket
** Co's Q4 adjusted EPS of $1.50 narrowly misses estimates of $1.51 - data compiled by LSEG
** Q4 revenue falls 1.8% to $4.93 billion, but beats estimates of $4.86 billion
** Co also sees adjusted EPS for fiscal 2025 to rise by mid-to-high single-digits compared with estimates of 3.2% increase
** KMB rose ~8% in 2024
(Reporting by Neil J Kanatt in Bengaluru)
((Neil.JKanatt@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。